Health Care/Hospital

New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry

TOKYO, April 15, 2021 /PRNewswire/ -- Today, pioneering life science organizations seeking to navigate Japanese market entry gained a new pathway. Shonan Health Innovation Park ("Shonan iPark", Kanagawa Prefecture,Japan) announced today new membership offerings for innovation and expansion-focuse...

2021-04-15 21:00 1240

Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

SUZHOU, China, April 15, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that it has received approval from t...

2021-04-15 18:20 4722

Generali Redefines Critical Illness Coverage with Unlimited Claims[1] even After Major Claims are Made

HONG KONG, April 15, 2021 /PRNewswire/ -- Generali Hong Kong introduces LionGuardian Beyondand LionGuardian PlusOne, enhanced critical illness plans with unlimited claims[1] for the most concerned critical illnesses[2] - cancer, stroke and heart attacks.

2021-04-15 18:19 2480

Exyte to build Dexcom's first manufacturing facility in Asia

STUTTGART, Germany and PENANG, Malaysia, April 15, 2021 /PRNewswire/ -- Exyte, world-renowned for the design and construction of high-tech facilities, has been awarded a fast-track project for Dexcom inPenang, Malaysia. This is the first manufacturing facility for the U.S.-based diabetes care tec...

2021-04-15 18:07 2624

LightAir IonFlow fights the spread of COVID-19

STOCKHOLM, April 15, 2021 /PRNewswire/ -- LightAir IonFlow virus inhibitor is scientifically and independently proven on viruses in the air and on surfaces, and together with the development of vaccines, can actively contribute to halting the spread of COVID-19. New tests from a leading European...

2021-04-15 17:45 1756

Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive

SINGAPORE, April 15, 2021 /PRNewswire/ -- Juniper Biologics, a science-led healthcare company focused on researching, developing & commercialising novel therapies, has announced the appointment of celebrated pharmaceutical executive Raman Singh to the role of Chief Executive. Juniper Biologics wi...

2021-04-15 16:30 2053

Mentice appoints Pontus Appelqvist as Vice President and GM for Asia Pacific

STOCKHOLM, April 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager forAsia Pacific. Po...

2021-04-15 16:21 1859

New clinical study shows JOYSBIO COVID-19 neutralizing antibody rapid test nearly 98% accurate in verifying antibodies after vaccination

TIANJIN, China, April 15, 2021 /PRNewswire/ -- In a major breakthrough for testing COVID-19 immunity, JOYSBIO, a Chinese medical device manufacturer, just announced the completion of a clinical study inItaly, showing their COVID-19 neutralizing antibody rapid test kit is 98.05% effective in detec...

2021-04-15 14:20 2398

Seegene's Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic tests, the largest tender in history

* Seegene's Italian subsidiary to supply some 7.15 million COVID-19 tests to 17 regions there * S. Korean biotechnology firm to expand its influence in Italy's PCR diagnostic industry SEOUL, South Korea, April 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics ...

2021-04-15 14:19 1577

US online retailer iHerb launches a promotional event during April

HONG KONG, April 15, 2021 /PRNewswire/ -- With April here before we realize it, many are already making travel plans and developing a routine for getting back in shape, signaling their pursuit of a happier and healthier lifestyle. The demand for nutritional supplements that enhance health is on t...

2021-04-15 10:09 1937

Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

HANGZHOU, China, April 14, 2021 /PRNewswire/ -- Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the global phase III clinical trial (BURAN) at Shanghai Eastern Hospital Medical Center inChin...

2021-04-15 09:00 2048

Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer

SHANGHAI, April 15, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater ...

2021-04-15 08:36 4874

Kintor Pharmaceutical and Visum Announced Strategic Partnership to Expand Proxalutamide Manufacturing

SUZHOU, China, April 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, recently announced a strategic partnership with Hain...

2021-04-14 22:18 5068

Havas Health & You Strengthens Capabilities in Innovation and Customer Experience

Adds Network Chief Experience Officer Role and Co-Managing Directors of Innovation Engine, Havas NOW NEW YORK, April 14, 2021 /PRNewswire/ -- The last 12-18 months has dawned a new era in health, along with new expectations of companies across the health spectrum. Adding to the already fast-pace...

2021-04-14 21:35 1418

Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

SHANGHAI, April 14, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater ...

2021-04-14 21:33 5933

Gannex Announces the First Cohort Dosed in a U.S. Clinical Study with THR-β Agonist ASC41

SHANGHAI, April 14, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the dosing of the first cohort in the U.S. Phase I cli...

2021-04-14 20:00 2619

BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology

VANCOUVER, BC, April 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, is pleased to announce the results of a clinical study conducted by ProCare Health Iberia...

2021-04-14 20:00 6397

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery

SINGAPORE, April 14, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, dev...

2021-04-14 19:15 1767

GeneLeap Presents New Preclinical Data for Hydrogel Encapsulated TLR9 Agonist at AACR 2021

BOSTON, April 14, 2021 /PRNewswire/ -- GeneLeap Bio., a subsidiary of Luye Life Sciences specializing in the development of nucleic acid therapeutics, presented an ePoster entitled 'Hydrogel encapsulated TLR9 agonists show sustained tumor growth inhibition and prolong survival of CT26 tumor-beari...

2021-04-14 14:54 1273

New Study Reveals That Stress Causes People's Minds to Wander Close to 60% of the Workday

Sleep, purpose and a daily mind training practice are significant contributors to focus and productivity. NEW YORK, April 14, 2021 /PRNewswire/ -- People report that their minds wander at work 37% of the time, and stress increases mind-wandering by 2-3 times, according toThe Mind at Work study b...

2021-04-14 00:54 1689
1 ... 526527528529530531532 ... 807